Latest Financial Results News

Page 321 of 328
Acrux Limited has launched its Nitroglycerin 0.4% Ointment and successfully raised nearly $4 million, positioning the specialty pharma company for sustained revenue growth.
Victor Sage
Victor Sage
30 Jan 2025
Zip Co Limited has posted record-breaking second quarter results for FY25, driven by exceptional holiday trading and robust growth in the US and ANZ markets. The company reported a 24.8% increase in Total Transaction Volume and a 50.2% rise in cash EBTDA.
Claire Turing
Claire Turing
30 Jan 2025
Beforepay Group has reported a strong Q2 FY25 with record revenue exceeding $10 million and a growing active user base, while introducing its new Personal Loan product.
Claire Turing
Claire Turing
30 Jan 2025
Articore Group reveals a strategic restructure delivering significant cost savings and improved margins, even as marketplace revenue continues to decline. The launch of a new product, Dashery, aims to diversify revenue streams.
Victor Sage
Victor Sage
30 Jan 2025
Change Financial Limited reported a robust Q2 FY25 with revenue surging 53% year-on-year, driven by its expanding PaaS platform, while strategically exiting its loss-making US operations to sharpen focus on Australia and New Zealand.
Victor Sage
Victor Sage
30 Jan 2025
Doctor Care Anywhere delivered positive cash flow and revenue growth at the top of guidance in Q4 2024, while navigating a strategic shift with new leadership appointments and the closure of secondary care pathways.
Ada Torres
Ada Torres
30 Jan 2025
MedAdvisor Limited reported a significant 38.6% drop in 2Q FY25 revenue due to vaccine program deferrals but expects a stronger second half driven by a diversified US pipeline and cost-saving initiatives.
Ada Torres
Ada Torres
30 Jan 2025
Alcidion Group Limited reported robust Q2 FY25 sales of $13.1 million and improved cash flow, reinforcing its forecast to achieve EBITDA and cashflow positivity by the end of FY25.
Victor Sage
Victor Sage
30 Jan 2025
Clever Culture Systems Ltd has achieved a key cashflow break-even milestone in Q4 2024, driven by strong sales growth from major pharmaceutical clients including AstraZeneca and Bristol Myers Squibb. The company is also advancing its product line with a new APAS® Contact Plate capability set for mid-2025 launch.
Victor Sage
Victor Sage
30 Jan 2025
Adriatic Metals delivered a strong Q4 2024 with 934koz silver equivalent produced, setting the stage for commercial production at Rupice Mine in Q1 2025. The company’s financial footing and expansion plans signal confidence in scaling operations.
Maxwell Dee
Maxwell Dee
29 Jan 2025
Adriatic Metals has transitioned from development to production, delivering strong silver equivalent output in Q4 2024 despite extreme weather disruptions, and has updated its 2025 guidance with ambitious expansion plans.
Maxwell Dee
Maxwell Dee
29 Jan 2025
Energy Action Limited reports a strong positive operating cash flow of $1.08 million in Q2 FY25, boosted by customer receipts and an R&D tax rebate, while advancing its AI-driven energy platform Utilibox to fuel future growth.
Maxwell Dee
Maxwell Dee
29 Jan 2025